前收市價 | 0.2000 |
開市 | 0.2000 |
買盤 | 0.0000 |
賣出價 | 0.0500 |
拍板 | 4.50 |
到期日 | 2024-06-21 |
今日波幅 | 0.2000 - 0.2000 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 412 |
Esperion's (ESPR) Nilemdo & Nustendi get the European Commission's nod for label expansion based on data from the CLEAR Outcomes study.
Esperion's (ESPR) first-quarter earnings and sales beat estimates on the back of better-than-expected collaboration revenues.
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q1 2024 Earnings Call Transcript May 7, 2024 Esperion Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.00032, expectations were $-0.17. ESPR isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for […]